Vanda Pharmaceuticals has named Richard Gulino as Vanda's Senior Vice President, General Counsel and Secretary. Mr. Gulino has over 20 years of strategic and legal experience representing life sciences and healthcare companies.
"I am very pleased to welcome Rick to the Vanda executive management team," said Mihael H. Polymeropoulos, M.D., President and CEO of Vanda. "He is an exceptional leader and lawyer and brings a wealth of life science experience that we expect will prove instrumental as we continue to execute our global strategy."
Prior to joining Vanda, Mr. Gulino served as Vice President and General Counsel of Ameritox, Ltd., a clinical drug testing laboratory. Prior to this position, Mr. Gulino was Vice President and Deputy General Counsel at Cephalon, Inc., a global biopharmaceutical company specializing in discovering, developing and marketing novel central nervous system, pain and oncology medications, where he led the corporate/commercial legal function.
Before joining Cephalon, Mr. Gulino served as a senior commercial attorney at Zeneca, Inc. Mr. Gulino began his legal career in private practice with Dow, Lohnes & Albertson in Washington, DC. Mr. Gulino received his Bachelor of Arts in history from Colgate University and his Juris Doctor with high honors from Duke University School of Law.